Basis: FMP quote market capitalization / four-quarter operating cash flow less absolute capital expenditures. Source: stored company filings and market data; unavailable inputs remain N/A.
The Price/FCF ratio is N/A as of 2026-10-06T20:42:58.005Z.
Calculation as of: 2026-10-06T20:42:58.005Z.
Quote observation: 2026-10-06T20:00:00.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 87d00981f6afc2d6fb42b8babadf75d30967326f42a5e12d4c63051d6ceded83
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
PRICE/FCF RATIO
N/A
Market Cap
$137.80M
Price/FCF Ratio
523.02
TTM Avg
1083.05
3Y Avg
1083.05
5Y Avg
1083.05
Market Cap
$139.84M
Price/FCF Ratio
N/A
TTM Avg
34.10
3Y Avg
34.10
5Y Avg
34.10
Market Cap
$131.21M
Price/FCF Ratio
172.65
TTM Avg
111.34
3Y Avg
100.72
5Y Avg
72.71
| NAME | MARKET CAP | PRICE/FCF RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Atrium Therapeutics, Inc. (RNA) | $136.67M | N/A | N/A | N/A | N/A |
| Organigram Global Inc. (OGI)vs › | $136.57M | N/A | N/A | N/A | N/A |
| KORU Medical Systems, Inc. (KRMD)vs › | $137.80M | 523.02 | 1083.05 | 1083.05 | 1083.05 |
| Immuneering Corporation (IMRX)vs › | $139.04M | N/A | N/A | N/A | N/A |
| Alpha Cognition Inc (ACOG)vs › | $139.47M | N/A | N/A | N/A | N/A |
| Sutro Biopharma, Inc. (STRO)vs › | $139.84M | N/A | 34.10 | 34.10 | 34.10 |
| Freenome, Inc. (FRNM)vs › | $133.45M | N/A | N/A | N/A | N/A |
| LifeMD, Inc. (LFMD)vs › | $132.03M | N/A | 63.37 | 576.34 | 569.67 |
| AirSculpt Technologies, Inc. (AIRS)vs › | $131.21M | 172.65 | 111.34 | 100.72 | 72.71 |
| Health Catalyst, Inc. (HCAT)vs › | $130.79M | 10.01 | 13.06 | 13.06 | 13.06 |
P/FCF Ratio
N/A
FCF Yield
N/A
P/FCF measures market price relative to free cash flow per share. Free cash flow is operating cash flow after capital expenditures.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
